You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Prostate cancer

Degarelix for treating advanced hormone-dependent prostate cancer

Technology appraisal guidance
Reference number: TA404
Published: 24 August 2016

Guidance
Tools and resources
Information for the public
Evidence
History

Tackle Prostate Cancer

Appeals received
Initial scrutiny letter
Response to scrutiny letter
Final scrutiny letter
Response to final scrutiny letter
Vice Chair of NICE's final response

This page was last updated: 25 June 2014